Clinicopathologic characteristics, prognostication and treatment outcomes for myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-U): Mayo Clinic-Moffitt Cancer Center study of 135 consecutive patients

Leukemia. 2020 Feb;34(2):656-661. doi: 10.1038/s41375-019-0574-x. Epub 2019 Sep 11.

¹ Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
² Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
³ Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
⁴ Division of Hematopathology, Department of Pathology, Mayo Clinic, Rochester, MN, USA.
⁵ Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
⁶ Division of Hematopathology, Department of Pathology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
⁷ Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA. [email protected].
⁸ Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA. [email protected].

^# Contributed equally.

No abstract available

Publication types